Hongxin Biology
company
About
Hongxin Bio is an mRNA drug developer, focusing on nucleic acid drug delivery and RNA drug development.
- 11 - 50
Highlights
Details
- Last Funding Type
- Angel
- Industries
- Biopharma,Biotechnology,Medical
- Founded date
- Jan 1, 2021
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Hongxin Biology has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Dec 30, 2022 from a Angel round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 30, 2022 | Angel | — | 2 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Hongxin Biology is funded by 2 investors.
Hongtao Capital
and Nanling Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Angel |
|
|
— | Angel |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
